Geoffrey D. Mowatt

First Year of Call
Ontario, 2006

Areas of Practice
Health Law

Description
Geoff Mowatt is an experienced patent litigator and strategist, as well as a skilled regulatory and compliance advisor, with a particular emphasis on strategic counselling to innovative life sciences clients.

As a certified specialist in patent law, Geoff has experience in all aspects of complex patent litigation, ranging from pre-litigation opinions to appearing before the Ontario Court, Federal Court, and Federal Court of Appeal. He has worked with counsel in other jurisdictions, including the United States, Europe and Australia, to co-ordinate the Canadian part of multi-jurisdictional lawsuits. Geoff has extensive experience with proceedings under the Patented Medicines (Notice of Compliance) Regulations, including patent disputes related to innovative small molecule drugs, biologics, formulations, and dosage forms.

Geoff also provides strategic advice to the firm’s innovative life sciences clients on regulatory and compliance issues for pharmaceuticals, biologics, medical devices, and healthcare. His experience includes life cycle management and data protection, product and establishment licensing, approval pathways, drug marketing/advertising and interactions with healthcare professionals/institutions, drug reimbursement/pricing, Form IV patent listing, Certificates of Supplemental Protection, and the implications of international trade agreements.

Geoff has been recognized by LMG Life Sciences for his pragmatic patent strategy expertise and his adept regulatory advice, being shortlisted in Canada for both Patent Strategy Practitioner of the Year in 2022 and Regulatory Attorney of the Year in 2023.

Geoff also has experience with trademark litigation and procurement, including providing opinions and advice on registrability and freedom to operate, as well as brand strategy, trademark prosecution, and general trademark litigation.

Geoff speaks and writes frequently on intellectual property litigation and developments related to pharmaceuticals, biologics, biotechnology, and medical devices. Geoff is the past-chair of the Canadian Bar Association Biotechnology Committee, and regularly lectures at the Masters of Biotechnology program at the University of Toronto. Geoff holds a M.Sc. from the University of Toronto and worked for two years as a consultant at an engineering firm prior to attending law school.